A medicine that uses a combination of gene editing and probiotics to treat autoimmune disorders. The medicine would contain a probiotic strain that has been genetically modified to express specific proteins that help to regulate the immune system. The patient would take the medicine orally, and the probiotics would colonize the gut microbiome, where they would begin to produce the immune-regulating proteins. These proteins would help to reduce inflammation and prevent the immune system from attacking the body's own tissues, which is often the cause of autoimmune disorders. The medicine could potentially be used to treat a wide range of autoimmune disorders, including rheumatoid arthritis, multiple sclerosis, and type 1 diabetes.
